Do complement, platelet, and neutrophil oxidative pathways form a self-reinforcing loop that sustains thromboinflammation and elevated D-dimer?

The interplay between the complement system, platelet activation, and neutrophil oxidative pathways represents a powerful "triple-axis" that drives sustained thromboinflammation. Research indicates that these systems do not operate in isolation but rather form a self-reinforcing feed-forward loop that maintains a prothrombotic environment and leads to measurable clinical markers like D-dimer.

Mechanistic synergy and feed-forward loops

The reinforcement between these pathways occurs through specific molecular and cellular interactions:

• Complement-Neutrophil Axis: Anaphylatoxins C3a and C5a are central integrators. C5a, via its receptor C5aR1, directly stimulates neutrophils to undergo oxidative burst and release Neutrophil Extracellular Traps (NETs).
• Platelet-Neutrophil Interaction: Activated platelets release P-selectin and CD40L, which facilitate neutrophil recruitment. Furthermore, platelet-derived histones and damage-associated molecular patterns (DAMPs) act as potent triggers for NETosis, providing a bioactive scaffold for further thrombus formation.
• Oxidative Reinforcement: Neutrophil-derived myeloperoxidase (MPO) and reactive oxygen species (ROS) create an oxidative environment that triggers both the classical and alternative complement pathways. MPO-driven oxidative stress also promotes sC5b-9 (membrane attack complex) deposition, which further activates platelets.

Impact on thromboinflammation and D-dimer

The clinical consequence of this tripartite activation is a state of chronic or persistent thromboinflammation characterized by:

• Sustained Fibrin Turnover: NETs act as a physical scaffold for fibrin deposition and stabilize fibrin networks by incorporating Factor XIII-A and alpha-defensins. This continuous cycle of fibrin formation and subsequent degradation leads to the ongoing elevation of D-dimer, a key marker of fibrinolysis.
• Microvascular Thrombosis: The localization of coagulation factors (such as FXII) to the NET surface, combined with complement-mediated endothelial injury, creates a persistent procoagulant state often seen in conditions like post-acute sequelae of COVID-19 (PASC) or chronic inflammatory diseases.
• Pathway Amplification: Clinical data show that patients with high levels of NET markers and complement activation products frequently exhibit significantly higher D-dimer levels (e.g., in cohorts with severe infections or systemic inflammation), reflecting active intravascular coagulation.

Bottom line

The claim is strongly supported by mechanistic and clinical evidence. The convergence of complement activation, platelet signaling, and neutrophil oxidative pathways creates a stabilized prothrombotic environment through NETosis and molecular crosstalk, directly sustaining the thromboinflammatory state and the resulting elevation of D-dimer levels.